Guard Therapeutics International AB (publ)
556755-3226ActiveSwedish biotech developing novel kidney disease therapies based on proprietary peptides.
Biotechnology Companyguardtherapeutics.com
Overview
- 5–9
- Employees
- ≤1K SEK
- Revenue
- 2008
- Founded
Key Decision Makers
Tobias L Agervald
CEO
@guardtherapeutics.com+46867XXXXX
Karin Botha
CFO
Khatereh Ahmadi
Board Member
Torbjörn Larsson
Head of Chemistry, Manufacturing and Control
+9 more contacts in Funnelfeedr
Description
Guard Therapeutics is a Swedish clinical-stage biotechnology company dedicated to developing novel therapies for kidney diseases, addressing significant unmet medical needs. The company's drug candidates are uniquely based on the body's own protein, alpha-1-microglobulin. Their lead candidate, RMC-0...
ASAMEDIC AS